Argenx
ARGX
#617
Rank
โ‚น2.735 T
Marketcap
โ‚น44,385
Share price
1.31%
Change (1 day)
1.85%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น260.26 B

According to Argenx 's latest financial reports the company has โ‚น260.26 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Argenx - Cash on Hand chart (from 2021 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น181.43 B4.19%
2021-12-31โ‚น174.13 B-2.27%
2020-12-31โ‚น178.18 B48.56%
2019-12-31โ‚น119.93 B133.06%
2018-12-31โ‚น51.46 B55.62%
2017-12-31โ‚น33.06 B354.76%
2016-12-31โ‚น7.27 B116.62%
2015-12-31โ‚น3.35 B-35.98%
2014-12-31โ‚น5.24 B91.54%
2013-12-31โ‚น2.73 B73.54%
2012-12-31โ‚น1.57 B-24.75%
2011-12-31โ‚น2.09 B235.62%
2010-12-31โ‚น0.62 B